Contract

Contracts for the supply of Measles, Mumps and Rubella (MMR) vaccines

  • Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency

F03: Contract award notice

Notice identifier: 2023/S 000-021083

Procurement identifier (OCID): ocds-h6vhtk-039a78

Published 21 July 2023, 11:50am



Section one: Contracting authority

one.1) Name and addresses

Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency

Nobel House, 17 Smith Square

London

SW1P 3JR

Contact

Chantal Jockel

Email

chantal.jockel@dhsc.gov.uk

Country

United Kingdom

Region code

UKI32 - Westminster

Internet address(es)

Main address

https://www.gov.uk/government/organisations/uk-health-security-agency

Buyer's address

https://www.gov.uk/government/organisations/uk-health-security-agency

one.2) Information about joint procurement

The contract is awarded by a central purchasing body

one.4) Type of the contracting authority

Ministry or any other national or federal authority

one.5) Main activity

Health


Section two: Object

two.1) Scope of the procurement

two.1.1) Title

Contracts for the supply of Measles, Mumps and Rubella (MMR) vaccines

Reference number

CM/PHV/24/125671

two.1.2) Main CPV code

  • 33651640 - Measles-mumps-rubella vaccines

two.1.3) Type of contract

Supplies

two.1.4) Short description

Contracts for the supply of Measles, Mumps and Rubella (MMR) vaccines

two.1.6) Information about lots

This contract is divided into lots: No

two.1.7) Total value of the procurement (excluding VAT)

Value excluding VAT: £1

two.2) Description

two.2.3) Place of performance

NUTS codes
  • UK - United Kingdom
Main site or place of performance

UK

two.2.4) Description of the procurement

The provision of a vaccine to protect against measles, mumps and rubella, to be used as part of the national childhood immunisation programme.
Deliveries will be required over a period of 2 years, with an option to extend for up to an additional 24 months.

two.2.5) Award criteria

Quality criterion - Name: Comparison with specification / Weighting: N/A

Quality criterion - Name: Risk to programme delivery / Weighting: N/A

Quality criterion - Name: Social value / Weighting: N/A

Cost criterion - Name: Benchmark price / Weighting: N/A

Cost criterion - Name: Vaccine price / Weighting: N/A

Cost criterion - Name: Additional costs / Weighting: N/A

Cost criterion - Name: Additional savings / Weighting: N/A

Cost criterion - Name: Storage costs / Weighting: N/A

two.2.11) Information about options

Options: Yes

Description of options

This contract has the option to be extended for a period or periods up to an additional 24 months

two.2.13) Information about European Union Funds

The procurement is related to a project and/or programme financed by European Union funds: No


Section four. Procedure

four.1) Description

four.1.1) Type of procedure

Open procedure

four.1.8) Information about the Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: Yes

four.2) Administrative information

four.2.1) Previous publication concerning this procedure

Notice number: 2023/S 000-002278


Section five. Award of contract

A contract/lot is awarded: Yes

five.2) Award of contract

five.2.1) Date of conclusion of the contract

17 July 2023

five.2.2) Information about tenders

Number of tenders received: 2

Number of tenders received from SMEs: 0

Number of tenders received by electronic means: 2

The contract has been awarded to a group of economic operators: No

five.2.3) Name and address of the contractor

GlaxoSmithKline UK Ltd - Vaccines

980 Great West Road, Brentford, Middlesex

Brentford

TW8 9GS

Country

United Kingdom

NUTS code
  • UKI - London
The contractor is an SME

No

five.2.4) Information on value of contract/lot (excluding VAT)

Initial estimated total value of the contract/lot: £1

Total value of the contract/lot: £1


Section five. Award of contract

A contract/lot is awarded: Yes

five.2) Award of contract

five.2.1) Date of conclusion of the contract

17 July 2023

five.2.2) Information about tenders

Number of tenders received: 2

Number of tenders received from SMEs: 0

Number of tenders received by electronic means: 2

The contract has been awarded to a group of economic operators: No

five.2.3) Name and address of the contractor

MERCK SHARP and DOHME (UK) LIMITED

120 Moorgate

London

EC2M 6UR

Country

United Kingdom

NUTS code
  • UKI - London
National registration number

00233687

Internet address

www.msd-uk.com

The contractor is an SME

No

five.2.4) Information on value of contract/lot (excluding VAT)

Initial estimated total value of the contract/lot: £1

Total value of the contract/lot: £1


Section six. Complementary information

six.3) Additional information

The contracts are for the benefit of the Authority and NHS bodies along with any other non-NHS bodies which are necessary for the delivery of services or goods to NHS bodies, local authorities, other government departments or non-departmental public bodies charged with the delivery of healthcare or health related services in the United Kingdom, Crown Dependencies and British Overseas Territories including, without limitation, the National Assembly for Wales, the Northern Ireland Assembly, and Scottish Ministers. The resulting products delivered against the contracts may be made available to the UK devolved administrations, Crown Dependencies and British Overseas Territories to undertake their respective vaccination programmes.

Value - The contract value is withheld from publication pursuant to regulation 50(6)(b) of the Public Contracts Regulations 2015 (as amended) so as not to prejudice the legitimate commercial interest of the suppliers.

six.4) Procedures for review

six.4.1) Review body

The High Court

The Strand

London

WC2A 2LL

Country

United Kingdom

Internet address

https://www.judiciary.uk/courts-and-tribunals/high-court/